NCT01408394 - Safety and Tolerability Comparison of Immediate and Controlled Release Formulations of Ecopipam | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

May 31, 2012

Conditions

Healthy

Interventions

DRUG

Ecopipam immediate release form

Tablet containing 100 mg of the immediate release form of ecopipam

DRUG

90 mg controlled release form

This is the 90 mg controlled release form

DRUG

180 mg controlled release form

This is the 180 mg controlled release capsule

Trial Locations (1)

SNBL Clinical Pharmacology Center, Inc., Baltimore